GSTP1 and cancer: This nitrobenzoxadiazole (NBD) derivative is a potent mechanism-based inhibitor of both human GSTP1-1 and GSTM2-2 and exhibits remarkable cytotoxicity towards various cultured cancer cell lines (IC50 values in the low micromolar/submicromolar range) [1].